




<rss xmlns:a10="http://www.w3.org/2005/Atom" version="2.0">
    <channel>
        <title>Heart Transplant</title>
        <link>http://www.acc.org/Feed?clinicalTopicID=2fbb8575-3ee6-4d6f-8bad-591a0603ecb0</link>
        <description>Clinical Topic Feed: Heart Transplant</description>
        <language>en</language>

        

                <item>
                    <title>CLASP II TR: TTVr With PASCAL System Improves Health Status in Patients With Symptomatic Severe TR</title>
<link>/Latest-in-Cardiology/Articles/2026/11/01/00/11/mon-125pm-clasp-tct-2026</link>                    <description>Among patients with symptomatic severe tricuspid regurgitation (TR), transcatheter tricuspid valve repair (TTVr) with the PASCAL system in addition to optimal medical therapy (OMT) showed significant improvement in health status at one year when compared to OMT alone and no significant difference in mortality or heart failure (HF) hospitalization...</description>
                    <pubdate>1793643900000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>HFSA 2026: ATTRibute-CM Analysis; LINK-HF2 Results; More</title>
<link>/Latest-in-Cardiology/Articles/2026/10/19/18/12/HFSA-2026</link>                    <description>New science presented at HFSA 2026 and simultaneously published in JACC: Heart Failure spans several evolving areas in heart failure (HF), from ATTR-CM biomarkers and measures of physical function to predictors of adverse outcomes in transplant recipients to artificial intelligence (AI) wearables enhancing discharge care following HF hospitalization.</description>
                    <pubdate>1792523820000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Eagle&#226;€™s Eye View: Clopidogrel vs. Aspirin Following PCI</title>
<link>/Latest-in-Cardiology/Articles/2026/07/01/12/47/eagles-eye-view-01jul2026</link>                    <description>In this week&#226;€™s View, Dr. Eagle looks at how genotype independently predicts heart failure outcomes in patients with hypertrophic cardiomyopathy (HCM).</description>
                    <pubdate>1782910140000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Genotype Independently Predicts HF Outcomes in Patients With HCM</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/06/23/13/25/Genotype-Independently-Predicts-HF-Outcomes</link>                    <description>In patients with hypertrophic cardiomyopathy (HCM), genotype, peak VO2, log NT-proBNP and LVEF independently predict heart failure (HF) outcomes, and combining these measures identified patients at higher risk of HF-related death or transplant, according to a recent study published in JACC: Heart Failure.</description>
                    <pubdate>1782228900000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Eagle&#226;€™s Eye View: Imaging Identifies HCM Patients at High-Risk of Adverse Outcomes </title>
<link>/Latest-in-Cardiology/Articles/2026/05/20/13/40/eagles-eye-view-20may2026</link>                    <description>In this week&#226;€™s View, Dr. Eagle reviews evidence supporting the use of cardiac magnetic resonance (CMR) and NT-proBNP in hypertrophic cardiomyopathy (HCM) risk assessment.</description>
                    <pubdate>1779288780000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>JACC Journals Science at ESC Heart Failure Congress 2026</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/05/11/15/12/JACC-Journals-Science-at-ESC-Heart-Failure-Congress-2026</link>                    <description>Findings from several studies presented at ESC Heart Failure Congress 2026 in Barcelona, Spain, were simultaneously published in JACC and JACC: Heart Failure, covering topics like arrhythmic burden in cardiac amyloidosis (CA), stroke and bleeding risk in CA...</description>
                    <pubdate>1778607960000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Hot Topics in Congenital and Pediatric Cardiology in the Year 2025</title>
<link>/Latest-in-Cardiology/Articles/2026/02/19/11/58/Hot-Topics-in-Congenital-and-Pediatric-Cardiology-in-the-Year-2025</link>                    <description>The pace of innovation in congenital and pediatric cardiology continued to accelerate in 2025, shaped by practice&#226;€‘defining guidelines, multicenter investigations, and growing bench&#226;€‘to&#226;€‘bedside translation.</description>
                    <pubdate>1771850460000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>REUP For DCD Feasible Regardless of Donor Age, Ischemic Time</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/01/22/18/26/REUP-For-DCD</link>                    <description>Rapid recovery with extended ultraoxygenated preservation (REUP) for donation after circulatory death (DCD) was found to be feasible regardless of donor age and ischemic time, according to a study published Jan. 26 in JAMA.</description>
                    <pubdate>1769520060000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>For the FITs | Fighting Against the Tide: Graduate Training in AHFTC</title>
<link>/Latest-in-Cardiology/Articles/2025/11/01/01/For-the-FITs</link>                    <description>Over the past four decades, the field of advanced heart failure/transplant cardiology (AHFTC) has undergone remarkable transformation in both clinical practice and fellowship training.</description>
                    <pubdate>1761999120000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>JACC in a Flash | LAAO Insights; Acoramidis Reduces CV Mortality, Rehospitalization; More</title>
<link>/Latest-in-Cardiology/Articles/2025/11/01/01/JACC-in-a-Flash</link>                    <description>Featured topics and Editors&#39; Picks from all of ACC&#39;s JACC Journals.</description>
                    <pubdate>1761998940000</pubdate>
                    <category>Articles and Stories</category>
                </item>

    </channel>
</rss>